Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Equity Ratio (2016 - 2026)

Aytu Biopharma has reported Equity Ratio over the past 15 years, most recently at 0.12 for Q4 2025.

  • Quarterly Equity Ratio fell 56.02% to 0.12 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.12 through Dec 2025, down 56.02% year-over-year, with the annual reading at 0.15 for FY2025, 34.92% down from the prior year.
  • Equity Ratio was 0.12 for Q4 2025 at Aytu Biopharma, down from 0.19 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.52 in Q2 2021 and troughed at 0.12 in Q4 2025.
  • The 5-year median for Equity Ratio is 0.28 (2023), against an average of 0.29.
  • Year-over-year, Equity Ratio skyrocketed 155.64% in 2021 and then tumbled 56.02% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.47 in 2021, then tumbled by 31.3% to 0.32 in 2022, then dropped by 22.73% to 0.25 in 2023, then rose by 5.75% to 0.26 in 2024, then tumbled by 56.02% to 0.12 in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Equity Ratio are 0.12 (Q4 2025), 0.19 (Q3 2025), and 0.15 (Q2 2025).